Product Information
NAPROXEN 125 MG/5 ML SUSPEN is a generic product labeled by Hikma Pharmaceuticals USA Inc., priced at $0.1912 per ML under NDC 00054363063. Its NADAC has been published 202 times since Nov 28, 2013.
FDA first approved this application on Mar 30, 1994. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
125 mg/5mL
Manufacturer
Hikma Pharmaceuticals USA Inc.NDC
00054363063
Classification
Generic
Dosage Form
SUSPENSION
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
NAPROXENApproval Type
Generic (ANDA)
FDA Application
ANDA074190FDA Approved
3/30/1994
TE Code
AB
On Market Since
2/24/2021
Pharmacological Classes
Price Statistics
The NADAC for NAPROXEN 125 MG/5 ML SUSPEN has been published 202 times since Nov 28, 2013, and over the history we have for it it has risen 172.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1912 per ML |
|---|---|
| All-time high | $0.9187 (Apr 10, 2024) |
| All-time low | $0.0703 (Nov 28, 2013) |
| 52-week high | $0.2346 |
| 52-week low | $0.1654 |
| Median price | $0.1854 |
| Average price | $0.2712 |
| Largest weekly change | +596.0% (Mar 20, 2024) |
| Weeks tracked | 202 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 39% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of NAPROXEN 125 MG/5 ML SUSPEN?
The current National Average Drug Acquisition Cost (NADAC) for NAPROXEN 125 MG/5 ML SUSPEN, manufactured by Hikma Pharmaceuticals USA Inc., is $0.1912 per ML (NDC 00054363063), effective Aug 19, 2026.
How has the price of NAPROXEN 125 MG/5 ML SUSPEN changed over time?
Over the history we have for it, the NADAC for NAPROXEN 125 MG/5 ML SUSPEN has risen 172.2%. It has been tracked across 202 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for NAPROXEN 125 MG/5 ML SUSPEN?
Since Nov 28, 2013, the NADAC for NAPROXEN 125 MG/5 ML SUSPEN has ranged from a low of $0.0703 (Nov 28, 2013) to a high of $0.9187 (Apr 10, 2024), with a median of $0.1854 per ML.
Are there cheaper alternatives to NAPROXEN 125 MG/5 ML SUSPEN?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, NAPROXEN 125 MG/5 ML SUSPEN, is $0.1173 per ML — about 39% below NAPROXEN 125 MG/5 ML SUSPEN.
Who manufactures NAPROXEN 125 MG/5 ML SUSPEN?
NAPROXEN 125 MG/5 ML SUSPEN (NDC 00054363063) is labeled by Hikma Pharmaceuticals USA Inc., and CMS classifies it as a generic product.